Tested Applications
| Positive WB detected in | mouse pancreas tissue |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
21578-1-AP targets INMT in WB, IHC, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag16121 Product name: Recombinant human INMT protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 67-263 aa of BC106903 Sequence: TIYQVLAACDSFQDITLSDFTDRNREELEKWLKKEPGAYDWTPAVKFACELEGNSGRWEEKEEKLRAAVKRVLKCDVHLGNPLAPAVLPLADCVLTLLAMECACCSLDAYRAALCNLASLLKPGGHLVTTVTLRLPSYVVGKREFSCVALEKEEVEQAVLDAGFDIEQLLHSPQSYSVTNAANNGVCCIVARKKPGP Predict reactive species |
| Full Name | indolethylamine N-methyltransferase |
| Calculated Molecular Weight | 263 aa, 29 kDa |
| Observed Molecular Weight | 29 kDa |
| GenBank Accession Number | BC106903 |
| Gene Symbol | INMT |
| Gene ID (NCBI) | 11185 |
| RRID | AB_10733240 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | O95050 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for INMT antibody 21578-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The INMT antibody (Cat# 21578-1-AP) has 5 total citations published in Frontiers in Pharmacology, BMC Cancer, Journal of Proteome Research, Computational Biology and Chemistry, and Korean Journal of Physiology and Pharmacology. Research fields span prostate cancer drug screening, hepatocellular carcinoma prognostic modeling, myocardial hypertrophy proteomics, HBV-associated HCC biomarker prediction, and age-related diurnal expression of inflammatory mediators in brain and peripheral blood.
| Species | Application | Title |
|---|---|---|
Front Pharmacol In silico high-throughput screening system for INMT activators in prostate cancer therapy. | ||
BMC Cancer Development and validation of a selenium metabolism regulators associated prognostic model for hepatocellular carcinoma | ||
J Proteome Res A Cluster of Potential Molecular Contributors in Myocardial-Tissue-Derived In Situ Proteomic Profiling Mediate Myocardial Hypertrophy Linked to Right Heart Dysfunction. | ||
Comput Biol Chem EHMT2 and INMT as methyltransferase related biomarkers predicting prognosis in HBV associated hepatocellular carcinoma. | ||
Korean J Physiol Pharmacol Age-related changes in diurnal expression of inflammatory mediators in the brain and peripheral blood of male and female mice |
